Back to Search
Start Over
AISF position paper on HCV in immunocompromised patients
- Source :
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 51(1)
- Publication Year :
- 2018
-
Abstract
- This report summarizes the clinical features and the indications for treating HCV infection in immunocompromised and transplanted patients in the Direct Acting Antiviral drugs era.
- Subjects :
- medicine.medical_specialty
Transplant Recipient
Comorbidity
Antiviral Agents
Organ transplantation
03 medical and health sciences
Immunocompromised Host
0302 clinical medicine
Internal medicine
Neoplasms
medicine
Immunocompromised patient
Humans
Chronic
Intensive care medicine
Antiviral Agent
Hepatology
business.industry
Gastroenterology
Hepatitis C, Chronic
medicine.disease
Hepatitis C
Organ transplant
HCV
Immunocompromised patients
Transplant Recipients
Immunocompetence
Italy
030220 oncology & carcinogenesis
HCV, Immunocompromised patients, Organ transplant
Position paper
Neoplasm
030211 gastroenterology & hepatology
business
Direct acting
Human
Subjects
Details
- ISSN :
- 18783562
- Volume :
- 51
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
- Accession number :
- edsair.doi.dedup.....4f76f82f941aca1095f360b525b8eb45